Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07114042

HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding

Moglobin, Albumin, Lymphocyte and Platelet Score as a Novel Predictor of Mortality and Re-bleeding in Patients With Upper Gastrointestinal Bleeding

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.

Detailed description

Study for evaluation of the utility of hemoglobin, Albumin, Lymphocyte and Platelat score in prediction of mortality and re\_bleeding in patient with upper gastrointestinal bleeding, Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUpper endoscopyPrediction of upper gastrointestinal r\_bleeding and mortality

Timeline

Start date
2025-08-08
Primary completion
2026-01-20
Completion
2026-02-01
First posted
2025-08-11
Last updated
2025-08-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07114042. Inclusion in this directory is not an endorsement.